Form D · Agriculture
NEO Farmaceuticals LLC
Cleveland, OH · CIK 0001709598
Offering snapshot reported Jun 27, 2017 · SEC filing
- Reported sold
- $3.98M Offering amount: $5M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jun 27, 2017 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 27, 2017 | Initial | $3,975,000 | No comparison | 16 | SEC filing |
| Jun 27, 2017 | Amendment | $3,975,000 | $0vs Jun 27, 2017 | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-289470
Source: Form D, filed Jun 27, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kevin Adelstein | Executive, Promoter |
| Michael Wager | Executive, Promoter |
Issuer details
Industry: Agriculture (See others in industry)
Address:Cleveland, OH, 44114